Finnrick - Ensuring a Safer and More Transparent Supply Chain

Free peptides test: now with paid endotoxins contamination option

Mai Peptide

Mai Peptide

Tirzepatide

Finnrick tested 6 samples of Tirzepatide (GLP-1 and GIP agonist) from Mai Peptide between 25 Nov 2025 and 19 Jan 2026. Test scores average below 4 or some scores below 3, and at least 6 tests, warrant a confident Finnrick Rating of E (Bad).

Finnrick Rating™
Mai Peptide
Tirzepatide
Tested 6 Samples
Last test 19 Jan 2026

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Tirzepatide tests from top-rated vendors:

All Tirzepatide tests from Mai Peptide

Samples are tested in commercial labs

Tests Count

6

Scores

AVG7.2MIN2.0MAX10.0

Last

19 Jan 2026

First

25 Nov 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
19 Jan 2026View10.060mg57mg-5.0%99.95% October 8 2025White Label / Silver Crimp / Pink CapLab EPublic
15 Jan 2026View7.430mg33.2mg+10.7%99.54%15734916854Red Label / Silver Crimp / Green CapLab EPublic
9 Jan 2026View8.130mg28mg-6.7%99.31%11/05/2025White Label / Silver Crimp / Black Cap Lab EPublic
1 Jan 2026View6.510mg9.2mg-8.0%99.70%(no batch ID)(no data)Lab GPublic
17 Dec 2025View9.530mg28.9mg-3.7%99.68%10-08-2025 White Label / Silver Crimp / Green CapLab EPublic
25 Nov 2025View2.020mg
⚠️ Sample does not contain Tirzepatide
10/8/2025 - Purple CapWhite Label / Silver Crimp / Violet CapLab EPublic